Hoth Therapeutics

Hoth Therapeutics

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease
Significant decrease in Aβ after acute treatment with HT-ALZ, supporting that HT-ALZ has the potential to modify Aβ plaque formation in the brain
Sponsored
Hoth Therapeutics Announces Submission of Orphan Designation Application for HT-KIT to Treat Mastocytosis
NEW YORK, NY December 21, 2021 /PRNewswire/  Hoth Therapeutics, Inc.
Sponsored
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Sponsored
© 2025 Benzinga | All Rights Reserved